Abstract: An open channel flow monitoring apparatus for measuring a fluid level is disclosed having a first sensor configured to obtain data indicative of a fluid level below a first threshold level, a second sensor configured to obtain data indicative of fluid level above a second threshold level, which is lower than the first threshold level, and both the first sensor and the second sensor are configured to obtain data indicative of the fluid level when the fluid level is between the first threshold level and the second threshold.

Abstract: A rotary dispenser (100) for unwinding a telecommunications cable (115) from a drum (110), the rotary dispenser comprising: a rotating portion (125) for supporting the drum and for permitting rotation of the drum about an axis of rotation; a fixed portion (120) supporting the rotating portion and configured to remain static relative to the rotating portion; a locating member (135) for centring the drum about the axis of rotation; a cable guide (145), coupled to the fixed portion, for receiving the telecommunications cable from the drum when the drum is mounted on the rotary dispenser and configured to support movement of the telecommunications cable through the cable guide as the rotating portion and the drum are rotated with the rotating portion; and an urging member for urging the cable guide away from the rotating portion so as to tension the telecommunications cable in use.

Abstract: An open channel flow monitoring apparatus for measuring a fluid level is disclosed having a first sensor configured to obtain data indicative of a fluid level below a first threshold level, a second sensor configured to obtain data indicative of fluid level above a second threshold level, which is lower than the first threshold level, and both the first sensor and the second sensor are configured to obtain data indicative of the fluid level when the fluid level is between the first threshold level and the second threshold.

Abstract: Methods for treating hyperglycemia disorders in a subject in need thereof and pharmaceutical compositions for the treatment of hyperglycemia disorders are disclosed. The methods include administering an effective amount of apolipoprotein A-IV to the subject. Also disclosed are methods for substantially restoring glucose tolerance in a subject in need thereof to a normal level and methods for lowering blood glucose levels in a subject having hyperglycemic disorders, including insulin resistant disorders, such as prediabetes, metabolic syndrome, polycystic ovary disease, type A syndrome, gestational diabetes, and endocrine conditions associated with hyperglycemia, including Cushing's Disease, glucagon excess (glucagon secreting tumors) and acromegaly.

Abstract: An abrasive article includes a bonded abrasive body having abrasive particles comprising microcrystalline alumina (MCA) contained within a bond material. In an embodiment, the bonded abrasive body has a strength ratio (MOR/MOE) of at least about 0.80. Additionally, the bonded abrasive body may have a MOR of at least 40 MPa for a MOE or at least about 40 GPa and the bonded abrasive body may be capable of grinding a workpiece that includes metal at a speed of at least about 60 m/s at a material removal rate of at least about 0.4 in3/min/in (258 mm3/min/mm).

Abstract: Methods for treating type two diabetes mellitus in a subject in need thereof and pharmaceutical compositions for the treatment of type two diabetes mellitus are disclosed. The methods include administering an effective amount of apolipoprotein A-IV to the subject. The pharmaceutical composition includes apolipoprotein A-IV formulated for administration to a subject for the treatment of type two diabetes mellitus. Also disclosed are methods for substantially restoring glucose tolerance in a subject in need thereof to a normal level and methods for lowering blood glucose levels in a subject in need thereof.

Abstract: An abrasive article can include a bonded abrasive body having abrasive particles comprising microcrystalline alumina (MCA) contained within a bond material. In an embodiment, the bonded abrasive body has a porosity of at least about 42 vol % of the total volume of the bonded abrasive body. Additionally, in an embodiment, the bonded abrasive body is capable of grinding a workpiece comprising metal at a speed of at least about 60 m/s at a material removal rate of at least about 0.4 in3/min/in (258 mm3/min/mm).

Abstract: Methods for treating type two diabetes mellitus in a subject in need thereof and pharmaceutical compositions for the treatment of type two diabetes mellitus are disclosed. The methods include administering an effective amount of apolipoprotein A-IV to the subject. The pharmaceutical composition includes apolipoprotein A-IV formulated for administration to a subject for the treatment of type two diabetes mellitus. Also disclosed are methods for substantially restoring glucose tolerance in a subject in need thereof to a normal level and methods for lowering blood glucose levels in a subject in need thereof.

Abstract: Methods for treating hyperglycemia disorders in a subject in need thereof and pharmaceutical compositions for the treatment of hyperglycemia disorders are disclosed. The methods include administering an effective amount of apolipoprotein A-IV to the subject. Also disclosed are methods for substantially restoring glucose tolerance in a subject in need thereof to a normal level and methods for lowering blood glucose levels in a subject having hyperglycemic disorders, including insulin resistant disorders, such as prediabetes, metabolic syndrome, polycystic ovary disease, type A syndrome, gestational diabetes, and endocrine conditions associated with hyperglycemia, including Cushing's Disease, glucagon excess (glucagon secreting tumors) and acromegaly.

Abstract: Methods for treating type two diabetes mellitus in a subject in need thereof and pharmaceutical compositions for the treatment of type two diabetes mellitus are disclosed. The methods include administering an effective amount of apolipoprotein A-IV to the subject. The pharmaceutical composition includes apolipoprotein A-IV formulated for administration to a subject for the treatment of type two diabetes mellitus. Also disclosed are methods for substantially restoring glucose tolerance in a subject in need thereof to a normal level and methods for lowering blood glucose levels in a subject in need thereof.

Abstract: An abrasive article including a bonded abrasive body having a bond material present in an amount of not greater than about 15 vol % for the total volume of the body, abrasive particulate material contained in the bond material, the abrasive particulate material including abrasive agglomerates and unagglomerated abrasive particles, wherein the body comprises an abrasive particulate ratio (APp:APagg) within a range between 3:1 and about 1:3, wherein APp represents the amount (vol %) of unagglomerated abrasive particles present in the body and APagg represents the amount (vol %) of abrasive agglomerates present in the body, and a porosity of at least about 42 vol % of the total volume of the bonded abrasive body.

Abstract: Methods for treating type two diabetes mellitus in a subject in need thereof and pharmaceutical compositions for the treatment of type two diabetes mellitus are disclosed. The methods include administering an effective amount of apolipoprotein A-IV to the subject. The pharmaceutical composition includes apolipoprotein A-IV formulated for administration to a subject for the treatment of type two diabetes mellitus. Also disclosed are methods for substantially restoring glucose tolerance in a subject in need thereof to a normal level and methods for lowering blood glucose levels in a subject in need thereof.

Abstract: An abrasive article including a bonded abrasive body having a bond material present in an amount of not greater than about 15 vol % for the total volume of the body, abrasive particulate material contained in the bond material, the abrasive particulate material including abrasive agglomerates and unagglomerated abrasive particles, wherein the body comprises an abrasive particulate ratio (APp:APagg) within a range between 3:1 and about 1:3, wherein APp represents the amount (vol %) of unagglomerated abrasive particles present in the body and APagg represents the amount (vol %) of abrasive agglomerates present in the body, and a porosity of at least about 42 vol % of the total volume of the bonded abrasive body.

Abstract: An abrasive article can include a bonded abrasive body having abrasive particles comprising microcrystalline alumina (MCA) contained within a bond material. In an embodiment, the bonded abrasive body has a porosity of at least about 42 vol % of the total volume of the bonded abrasive body. Additionally, in an embodiment, the bonded abrasive body is capable of grinding a workpiece comprising metal at a speed of at least about 60 m/s at a material removal rate of at least about 0.4 in3/min/in (258 mm3/min/mm).

Abstract: An abrasive article includes a bonded abrasive body having abrasive particles comprising microcrystalline alumina (MCA) contained within a bond material. In an embodiment, the bonded abrasive body has a strength ratio (MOR/MOE) of at least about 0.80.

Abstract: A separator is disclosed for moving a separated portion of an eye. The separator includes an upper surface. A lower planar surface is oriented at an angle with respect to the upper surface. The upper surface and the lower planar surface define an edge therebetween having a structure to remove a portion of an eye. The upper surface includes a structure to receive the removed portion of the eye and to roll the removed portion.

Abstract: An instrument (110) for rolling a thin ophthalmic lens and inserting the rolled lens into the eye comprises a body (112) in which a plunger (124) is slidable. A thin lens (156) is placed on a lens roller (130) which is slidable transversely of the instrument. The lens is rolled during the sliding movement into a tubular configuration. The rolled lens is then positioned in the instrument in a cylindrical cavity and ready for contact by a push-rod of the plunger (124) so that it is delivered from the instrument through a box in a tip portion (114) of the instrument.

Abstract: A separator that includes a body and a leading edge portion. The leading edge portion includes an upper planar surface oriented at an angle ranging from approximately 40° to 90° relative to a horizontal plane and a lower planar surface oriented at an angle ranging from approximately 0° to 30° relative to the horizontal plane, wherein the upper planar surface and the lower planar surface intersect one another so as to define a blunt leading edge and the leading edge portion is made of a material that has a hardness so as to separate an epithelial layer of an eye from an cornea stroma of said eye without substantially damaging said epithelial layer and wherein said blunt leading edge is incapable of cutting said stroma.

Abstract: A drive tool for optical surgery includes a handpiece containing a traverse motor and an oscillating motor, wherein the oscillating motor is axially driven through the handpiece by the traverse motor. A head assembly including a suction ring is mounted to the handpiece, and a separator drive assembly is positioned therein for advancement imparted by the traverse motor and oscillation imparted by the oscillating motor.